ReproCELL Incorporated (TYO:4978)

Catalent Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	45	-28	-303	-573	-811
Depreciation & Amortization	49	36	48	59	84
Loss (Gain) From Sale of Assets	-	58	131	66	23
Loss (Gain) From Sale of Investments	-	9	52	2	-
Loss (Gain) on Equity Investments	20	3	3	54	49
Other Operating Activities	159	287	50	154	195
Change in Accounts Receivable	-45	61	-88	-144	-20
Change in Inventory	-24	1	30	54	-54
Change in Accounts Payable	5	-137	-14	100	62
Change in Other Net Operating Assets	-203	-301	-49	-18	-176
Operating Cash Flow	6	-11	-140	-246	-648
Capital Expenditures	-86	-171	-151	-44	-60
Divestitures	-	-	-	-2	-
Sale (Purchase) of Intangibles	-9	-20	-10	-4	-4
Investment in Securities	-700	593	-921	-2,088	-1,352
Other Investing Activities	-	2	-5	-6	-
Investing Cash Flow	-795	404	-1,087	-2,144	-1,416
Long-Term Debt Repaid	-	-	-80	-	-
Total Debt Repaid	-	-	-80	-	-
Net Debt Issued (Repaid)	-	-	-80	-	-
Issuance of Common Stock	680	544	562	2,384	4
Financing Cash Flow	680	544	482	2,384	4
Foreign Exchange Rate Adjustments	-6	87	22	41	77
Miscellaneous Cash Flow Adjustments	-	-	1	-	-1
Net Cash Flow	-115	1,024	-722	35	-1,984
Free Cash Flow	-80	-182	-291	-290	-708
Free Cash Flow Margin	-2.69%	-7.50%	-9.85%	-12.98%	-55.05%
Free Cash Flow Per Share	-0.86	-2.13	-3.46	-3.82	-9.91
Cash Income Tax Paid	-1	2	1	1	1
Levered Free Cash Flow	-287.88	-511.25	-399.5	-294.38	-586
Unlevered Free Cash Flow	-287.88	-511.25	-399.5	-294.38	-586
Change in Net Working Capital	160	100	64	-99	-49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.